Compass Diversified (NYSE:CODI) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsBen Tapper - VP of Investor RelationsElias Sabo - Partner and CEOLarry Solow - Managing Director and PartnerRobert Dodd - Director of Specialty FinanceStephen Keller - Executive VP and CFOConference Call ParticipantsCris Kennedy - Research AnalystTimothy D'Agostino - Research AnalystOperatorGood afternoon, welcome to Compass Diversified's Fiscal 2025 Fourth Quarter Conference Call. Today's call is being r ...

Financial Data and Key Metrics Changes - Fourth quarter revenue was $49.1 million, exceeding guidance and up 2% year-over-year, marking the first quarter since Q1 2024 with simultaneous growth in both consumer and institutional businesses [4][19] - Non-GAAP adjusted EBITDA was positive $1.3 million, significantly improving by $6.8 million from Q4 2024 and beating guidance of -$2 million to break even [4][26] - Active members ended the year at 33.2 thousand, with ARPM reaching $364, a 21% increase year-over-year [21][22] Business Line Data and Key Metrics Changes - Consumer revenue was $41.6 million, a 6% increase year-over-year, representing 85% of total company revenues [19][22] - Institutional revenue was $7.2 million, accounting for 14% of total revenue, with bookings of $4.1 million, down 11% year-over-year due to funding delays [22][24] - Gross margin for Q4 was 66.8%, showing sequential improvement and driven by a shift to higher frequency learning memberships and price increases [23][24] Market Data and Key Metrics Changes - The U.S. academic tutoring market is estimated at approximately $20 billion per year, with the company currently serving fewer than 40,000 active members [6][7] - The demand for high-quality, personalized tutoring remains strong, with approximately 50 million students progressing through the K-12 and higher education systems in the U.S. each year [5][6] Company Strategy and Development Direction - The company aims to enhance personalized learning across its Live+AI platform, leveraging AI to improve user experience and operational efficiency [15][16] - Plans to return to active member growth through new marketing channels and an improved mobile experience are in place [16][17] - The focus for 2026 includes compounding gross margin and structural cost improvements, targeting break-even non-GAAP adjusted EBITDA for the full year [17][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the top-of-funnel trends and the ability to optimize customer acquisition and retention [39][40] - The completion of the new AI-native platform is expected to enhance engagement and operational speed, leading to better customer experiences [36][37] - The company anticipates continued gross margin improvement and operational efficiencies as it leverages AI capabilities [24][30] Other Important Information - The company completed the rollout of new learner and expert user experiences, receiving positive feedback from 85% of surveyed customers [12][22] - Significant reductions in sales and marketing expenses were noted, alongside a 22% year-over-year decline in headcount due to automation [25][26] Q&A Session Summary Question: Impact of new platform on engagement and retention - Management noted that the new platform allows for faster and more flexible operations, leading to improved engagement and retention [34][36] Question: Navigating changes in the search environment - Management expressed optimism about top-of-funnel trends and the ability to optimize discoverability and conversion rates [39][40]

Emergent BioSolutions (NYSE:EBS) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsFrank Vargo - TreasurerJoe Papa - President and CEORich Lindahl - EVP and CFOOperatorPlease be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Frank Vargo, Treasurer. Please go ahead.Frank VargoGood afternoon, everyone. Thank you for joining today as Emergent discusses their operational and financial results for the fourth quart ...

Alignment Healthcare (NasdaqGS:ALHC) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsJim Head - CFOJohn Kao - Founder and CEOJohn Ransom - Managing Director in Equity ResearchJohn Stansel - Equity Research VPSam Becker - Goldman SachsTiffany Yuan - BarclaysConference Call ParticipantsCraig Jones - Healthcare AnalystJessica Tassan - Vice President and Senior Research Analyst in Healthcare IT and Delivery SectorJonathan Yong - Executive Director and Senior Equity Research AnalystMatthe ...

Baldwin Insurance Group (NasdaqGS:BWIN) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAndrew Kligerman - Managing DirectorBonnie Bishop - Executive Director of Investor RelationsBrad Hale - CFOElyse Greenspan - Managing DirectorGregory Peters - Managing DirectorJosh Shanker - Managing DirectorPablo Singzon - Executive DirectorTommy McJoynt - DirectorTrevor Baldwin - CEOConference Call ParticipantsCharlie Lederer - Research AnalystOperatorGreetings, and welcome to the Baldwin Group' ...

Monster Beverage (NasdaqGS:MNST) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAndrea Teixeira - Managing Director, Equity Research - US Beverages, Household Products, and Personal CareDara Mohsenian - Managing Director - US Beverage and Household ProductsFilippo Falorni - Director, Equity Research - Lead Beverages and HPCGuy Carling - CEO of EMEA and OSPHilton Schlosberg - Vice Chairman and CEOMarc Astrachan - SVP of Investor RelationsMatthew Smith - Managing Director, Equity Rese ...

MARA (NasdaqCM:MARA) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsFred Thiel - Chairman and CEOGreg Lewis - Managing DirectorKevin Dede - Managing DirectorReggie Smith - Executive DirectorRobert Samuels - VP of Investor RelationsSalman Khan - CFOConference Call ParticipantsChris Brendler - Senior Research AnalystPaul Golding - Senior U.S. Payments and Digital Commerce AnalystOperatorGreetings, welcome to the MARA Q4 2025 Earnings Call. At this time, all participants are in a liste ...

Definitive Healthcare (NasdaqGS:DH) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsCasey Heller - CFOJonathan Paris - Chief Legal Officer and SecretaryKevin Coop - CEO and Board MemberConference Call ParticipantsBrian Peterson - Managing Director and Senior Equity Research AnalystGeorge Hill - Managing Director and Senior Equity Research AnalystJared Haase - Equity Research AnalystJeff Garro - Equity Research AnalystMatt Shea - Equity Research AnalystNone - AnalystJonathan ParisGood ...

PureCycle Technologies (NasdaqCM:PCT) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAnand Balaji - VP of Industrial Technology Equity ResearchDonald Carpenter - Incoming CFODustin Olson - CEOEric DeNatale - Director of Investor RelationsGerry Sweeney - Managing DirectorJaime Vasquez - Retiring CFOConference Call ParticipantsHassan Ahmed - Senior Equity AnalystJeffrey Campbell - Senior Analyst of Cleantech and SustainabilityLuke Persons - Sell-Side Equity Research Analyst of Clean T ...

Airgain (NasdaqCM:AIRG) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsJacob Suen - President and CEOMichael Elbaz - CFOConference Call ParticipantsAnthony Stoss - AnalystJaeson Schmidt - AnalystOperatorGood afternoon. Welcome to Airgain's fourth quarter and full year 2025 conference call. My name is Kevin, I'll be your operator for today's call. Joining us today are Airgain's President and CEO, Jacob Suen, and CFO, Michael Elbaz. As a reminder, this call will be recorded and made a ...